|
GMNN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00329999999749E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.20830000003036E-06 |
| Normal-vs-Stage2 |
1.720580E-03 |
| Normal-vs-Stage3 |
1.298780E-03 |
| Normal-vs-Stage4 |
4.745900E-02 |
| Stage1-vs-Stage2 |
3.431200E-01 |
| Stage1-vs-Stage3 |
7.110000E-02 |
| Stage1-vs-Stage4 |
1.258390E-01 |
| Stage2-vs-Stage3 |
6.284000E-01 |
| Stage2-vs-Stage4 |
5.253000E-01 |
| Stage3-vs-Stage4 |
7.645600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7213000000369E-06 |
| Normal-vs-AfricanAmerican |
7.394000E-04 |
| Normal-vs-Asian |
7.674000E-02 |
| Caucasian-vs-AfricanAmerican |
7.724100E-03 |
| Caucasian-vs-Asian |
8.586900E-04 |
| AfricanAmerican-vs-Asian |
1.917520E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.31120000004914E-06 |
| Normal-vs-Female |
8.234700E-04 |
| Male-vs-Female |
1.364500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.00879999999937E-05 |
| Normal-vs-Extreme_Weight |
1.0791000000232E-06 |
| Normal-vs-Obese |
2.25489999999828E-05 |
| Normal-vs-Extreme_Obese |
1.326190E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.380360E-01 |
| Normal_Weight-vs-Obese |
9.501800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.606000E-01 |
| Extreme_Weight-vs-Obese |
7.282300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.854400E-01 |
| Obese-vs-Extreme_Obese |
8.658400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.746100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.29470000000709E-05 |
| Normal-vs-Age(61-80Yrs) |
1.51550999999417E-05 |
| Normal-vs-Age(81-100Yrs) |
2.29610000013203E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.124400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.438300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.036200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.088200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.199300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.756000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.89991999999251E-05 |
| Normal-VS-Type2 PRCC |
1.03230000003673E-06 |
| Normal-VS-KIRP CIMP |
7.356000E-01 |
| Normal-VS-Unclassified PRCC |
1.01910000005478E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.810300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.02479999620454E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
7.864100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.515390E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.796200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.195630E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.73910000000888E-06 |
| Normal-vs-N1 |
1.258790E-01 |
| Normal-vs-N2 |
2.911600E-01 |
| N0-vs-N1 |
1.923910E-02 |
| N0-vs-N2 |
7.682200E-02 |
| N1-vs-N2 |
8.433200E-01 |
|
|
